Group items tagged

кража личности

Биометрика как надежное средство идентификации умрет

нехватка специалистов по ИТ-безопасности

In January, the biotech company Genentech reportedly committed $10 million for access to the DNA of 3,000 Parkinson’s patients and their families. A week later, Pfizer made a similar deal for the genomes of 5,000 people with lupus.

A trove of data could give scientists the tools they need to develop gene-specific drug therapies for certain diseases. “We are hoping to ultimately develop Parkinson’s medicines, for example, that actually modify the disease as opposed to just treating symptoms,”

“this has the possibility of not only helping us find new cures, but it also helps us create a genuine health care system as opposed to just a disease care system.”